Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlighted strong financial performance with record revenue and significant growth in operating income, net income, and free cash flow. The strategic outlook for 2026 is optimistic, with expectations of continued growth in key segments like government and commercial operations. While there are risks associated with forward-looking statements and reliance on non-GAAP measures, the overall sentiment is positive. The absence of shareholder return plans does not significantly impact the positive outlook due to strong financial metrics and optimistic guidance.
Revenue BWXT reported a record revenue of $2.5 billion for the full year 2025, representing a 10% year-over-year increase. This growth was driven by strong performance in the nuclear operations and advanced technologies segments.
Operating Income Operating income for 2025 was $400 million, up 12% year-over-year. The increase was attributed to improved operational efficiencies and higher-margin contracts in the nuclear operations segment.
Net Income Net income for 2025 was $250 million, reflecting a 15% increase compared to the previous year. This was due to a combination of higher revenues and cost management initiatives.
Earnings Per Share (EPS) Earnings per share for 2025 came in at $2.50, a 14% increase year-over-year, driven by the factors contributing to net income growth.
Free Cash Flow Free cash flow for 2025 was $300 million, up 20% from the prior year. This improvement was primarily due to better working capital management and higher cash generation from operations.
The selected topic was not discussed during the call.
Risks related to forward-looking statements: The company acknowledges that forward-looking statements involve risks and uncertainties, as described in their investor materials and SEC filings. These risks could impact the company's future performance.
Dependence on non-GAAP financial measures: The company frequently uses non-GAAP financial measures, which may not provide a complete picture of financial health and could pose challenges in accurately assessing performance.
Forward-looking statements: We will frequently discuss non-GAAP financial measures, which are reconciled to GAAP measures in the appendix of the earnings presentation that can be found on the Investors section of the BWXT website.
Dividend Program: No specific mention of a dividend program was found in the provided text.
Shares Buyback Program: No specific mention of a shares buyback program was found in the provided text.
The earnings call highlighted strong financial performance with record revenue and significant growth in operating income, net income, and free cash flow. The strategic outlook for 2026 is optimistic, with expectations of continued growth in key segments like government and commercial operations. While there are risks associated with forward-looking statements and reliance on non-GAAP measures, the overall sentiment is positive. The absence of shareholder return plans does not significantly impact the positive outlook due to strong financial metrics and optimistic guidance.
The earnings call summary and Q&A session indicate strong financial metrics with raised guidance across revenue, EBITDA, EPS, and free cash flow. The Kinectrics acquisition and government/commercial operations show promising growth. Despite some risks, such as lower initial margins and delayed Project Pele delivery, the market strategy with SMRs and medical segment growth is optimistic. The positive sentiment is further supported by the strategic partnerships and opportunities in nuclear energy. Overall, the outlook suggests a positive stock price movement, likely in the 2% to 8% range.
The earnings call summary shows strong strategic developments, including backlog growth, new contracts, and expansion plans, indicating positive future prospects. The Q&A section reveals proactive measures addressing bottlenecks and strategic partnerships, with analysts showing interest in nuclear and microreactor markets. Despite some uncertainties, the guidance remains optimistic, with a focus on revenue growth and margin expectations. The overall sentiment leans towards positive, suggesting a stock price increase over the next two weeks.
The earnings call summary shows strong financial performance with revenue, EBITDA, and EPS all up significantly year-over-year. Despite some margin pressure due to zirconium costs, management expects recovery in the second half. The Q&A indicates optimism about government contracts and nuclear projects, with strong support from the administration. The backlog and strategic acquisitions further enhance growth prospects. While there is some uncertainty in the ANPI program, overall sentiment remains positive, suggesting a likely stock price increase in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.